Norwegian Cancer Society launch campaign on threat of antimicrobial resistance to cancer treatment

14 June 2017

Wednesday, 14 June 2017 – Today, the Norwegian Cancer Society (NCS), have launched a new campaign calling on other organisations to raise awareness and take action against the threat of antimicrobial resistance (AMR) including antibiotic resistance, which could set cancer treatment back decades.

According to the World Health Organisation (WHO), antimicrobial resistance in of the greatest challenges our generation face. We risk losing one of the most important tools in modern medicine.

The Norwegian Cancer Society's campaign aims to address this growing threat by raising awareness of the potentially devastating effects Antimicrobial resistance can have for cancer patients. It is estimated that 1 in 5 cancer patients need antibiotics during their cancer treatment.

Many people are affected by cancer, and when we speak up in support of national governments efforts to fight antimicrobial resistance, we are in a position to impact the public opinon and medical communities for stronger adherence to the government advice.

Watch the video below, in which Norwegian Cancer Society Secretary General Ms Anne Lise Ryel and Norwegian MoH Mr Bent Høie call for urgent action on AMR​.

Rapid_diagnostics.png
Click image to zoom
Surveillance_protect_treatment.png
Click image to zoom

The treatment of cancer is complex and faces many challenges which are better addressed through collective efforts. UICC applauds the Norwegian Cancer Society for taking the lead in an issue that affects cancer patients the world over, and we encourage other UICC members to support the campaign and raise awareness of AMR in their own countries. 
Cary Adams, Chief Executive Officer, Union for International Cancer Control (UICC)

Get informed, take action and sign up to the campaign at www.kreftforeningen.no/amr

Follow the discussion on twitter: #AMRcancer

About the Norwegian Cancer Society

The Norwegian Cancer Society – a UICC Full Member – is a nation-wide, non-profit voluntary organisation. Their activities are funded by donations and fundraising, bequests and support from Norsk Tipping [state owned gaming company]. Several hundred thousand donors and members, as well as corporate sponsors, support the Society’s work. This broad support makes them the leading cancer NGO in Norway and contributes to a focused effort in the area of research funding, cancer care, cancer prevention, information and international collaboration.

Resource Information
Topics: 
antibiotics
antimicrobial resistance
cancer treatment
Advocacy
Campaign
Norwegian Cancer Society
global campaign
Last update: 
Wednesday 28 June 2017
Share